Pomalidomide for Kaposi Sarcoma in People With or Without HIV
A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals With or Without HIV
Sponsor: National Cancer Institute (NCI)
Listed as NCT01495598, this PHASE1/PHASE2 trial focuses on Kaposi Sarcoma and Sarcoma, Kaposi and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 39 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
39 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Sep 2022 — Dec 2022 [monthly]
Completed PHASE1_PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Completed PHASE1_PHASE2
▶ Show 34 earlier versions
-
Jun 2022 — Jul 2022 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
May 2022 — Jun 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2020 — May 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2019 — May 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2018 — Apr 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Apr 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .